DE60144284D1
(de)
|
2000-11-01 |
2011-05-05 |
Millennium Pharm Inc |
Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung
|
BR0313566A
(pt)
|
2002-10-15 |
2005-06-21 |
Otsuka Pharma Co Ltd |
Composto de 4-nitroimidazol 1-substituìdo, método para preparar um composto de 4-nitroimidazol, método para preparar um composto de 4-nitroimidazol 1-substituìdo, derivado de 4-nitroimidazol, e, composto
|
JP4761756B2
(ja)
*
|
2003-10-31 |
2011-08-31 |
大塚製薬株式会社 |
2,3−ジヒドロイミダゾ[2,1−b]オキサゾ−ル化合物
|
WO2005042542A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Otsuka Pharmaceutical Co., Ltd. |
2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis
|
TWI300409B
(en)
|
2004-02-18 |
2008-09-01 |
Otsuka Pharma Co Ltd |
Method for producing 4-nitroimidazole compound
|
US7485727B2
(en)
|
2004-03-31 |
2009-02-03 |
Nippon Soda Co., Ltd. |
Cyclic amine compound and pest control agent
|
JP4787529B2
(ja)
*
|
2004-04-09 |
2011-10-05 |
大塚製薬株式会社 |
医薬組成物
|
JP4789966B2
(ja)
*
|
2004-04-09 |
2011-10-12 |
大塚製薬株式会社 |
医薬組成物
|
EP1896453B1
(en)
*
|
2005-06-20 |
2009-12-02 |
Schering Corporation |
Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
|
AU2006273355B2
(en)
*
|
2005-07-28 |
2012-01-19 |
Otsuka Pharmaceutical Co., Ltd. |
Pharmaceutical composition comprising 2 , 3-dihydro-6-nitroimidazo [2 , 1-B] oxazole derivatives
|
TW201434467A
(zh)
*
|
2005-10-05 |
2014-09-16 |
Otsuka Pharma Co Ltd |
抗結核治療藥物及含彼之套組
|
JP5105818B2
(ja)
*
|
2005-10-05 |
2012-12-26 |
大塚製薬株式会社 |
医薬組成物
|
BRPI0616667B1
(pt)
|
2005-10-06 |
2017-07-18 |
Nippon Soda Co. , Ltd. |
Compounds of cyclical amine or salts thereof or non-oxides thereof, and agents for control of fever
|
TW200800268A
(en)
*
|
2005-11-04 |
2008-01-01 |
Otsuka Pharma Co Ltd |
Medicinal composition showing improved drug absorbability
|
CA2636929A1
(en)
*
|
2005-12-21 |
2007-07-12 |
Decode Genetics, Ehf |
Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
|
CA2640304A1
(en)
*
|
2006-02-13 |
2007-08-23 |
Laboratoires Serono S.A. |
Sulfonamide derivatives for the treatment of bacterial infections
|
JP2007297305A
(ja)
*
|
2006-04-28 |
2007-11-15 |
Daiso Co Ltd |
N−(2,3−エポキシ−2−メチルプロピル)フタルイミドの製造法
|
US8835426B2
(en)
*
|
2007-02-26 |
2014-09-16 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
AR070301A1
(es)
|
2007-05-08 |
2010-03-31 |
Otsuka Pharma Co Ltd |
Compuesto epoxi y metodo para producir el mismo
|
CL2008002199A1
(es)
*
|
2007-07-26 |
2009-10-23 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de 1,3-oxazin-2-ona; composicion farmaceutica que comprende a dichos compuestos; y uso para tratar una enfermedad asociada con la actividad de la 11beta-hidroxiesteroide deshidrogenasa tipo 1 (11beta-hsd1) tales como dislipidemia, hiperlipidemia, hipertension, obesidad y enfermedad cardiovascular, entre otras.
|
US20110281909A1
(en)
*
|
2007-08-15 |
2011-11-17 |
Glaxo Group Limited |
Substituted quinoline derivatives as h1 receptor antagonists
|
EP2205585A1
(en)
*
|
2007-10-16 |
2010-07-14 |
Glaxo Group Limited |
Quinoline derivatives used to treat inflammatory and allergic diseases
|
AR069207A1
(es)
*
|
2007-11-07 |
2010-01-06 |
Vitae Pharmaceuticals Inc |
Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
|
EP2229368A1
(en)
|
2007-12-11 |
2010-09-22 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
TW200934490A
(en)
*
|
2008-01-07 |
2009-08-16 |
Vitae Pharmaceuticals Inc |
Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
|
CA2712500A1
(en)
|
2008-01-24 |
2009-07-30 |
Vitae Pharmaceuticals, Inc. |
Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
EP2252598A2
(en)
*
|
2008-02-11 |
2010-11-24 |
Vitae Pharmaceuticals, Inc. |
1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
WO2009102460A2
(en)
*
|
2008-02-15 |
2009-08-20 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
EP2274287B1
(en)
*
|
2008-03-18 |
2016-03-09 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
US7666864B2
(en)
*
|
2008-03-26 |
2010-02-23 |
Global Alliance For Tb Drug Development |
Bicyclic nitroimidazole-substituted phenyl oxazolidinones
|
EP2291370B1
(en)
|
2008-05-01 |
2013-11-27 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
PL2300461T3
(pl)
*
|
2008-05-01 |
2013-09-30 |
Vitae Pharmaceuticals Inc |
Cykliczne inhibitory dehydrogenazy 11beta-hydroksysteroidów 1
|
CA2723039A1
(en)
|
2008-05-01 |
2009-11-05 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
EP2291373B1
(en)
*
|
2008-05-01 |
2013-09-11 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
EP2324017B1
(en)
|
2008-07-25 |
2014-12-31 |
Boehringer Ingelheim International GmbH |
INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
|
NZ590495A
(en)
|
2008-07-25 |
2012-10-26 |
Vitae Pharmaceuticals Inc |
Dihydropyridin-phenyl-3-oxazinan-2-ones as inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
US9540322B2
(en)
|
2008-08-18 |
2017-01-10 |
Yale University |
MIF modulators
|
BRPI0917394A2
(pt)
*
|
2008-08-18 |
2019-09-24 |
Univ Yale |
moduladores de mif
|
WO2010021409A1
(en)
|
2008-08-21 |
2010-02-25 |
Dynamit Nobel Gmbh Explosivstoff - Und Systemtechnik |
Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof
|
WO2010143007A1
(en)
*
|
2009-06-10 |
2010-12-16 |
Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik |
Method for the production of 2-halogeno-4-nitroimidazole
|
US8637505B2
(en)
|
2009-02-04 |
2014-01-28 |
Boehringer Ingelheim International Gmbh |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
TW201039034A
(en)
*
|
2009-04-27 |
2010-11-01 |
Chunghwa Picture Tubes Ltd |
Pixel structure and the method of forming the same
|
UA109255C2
(ru)
|
2009-04-30 |
2015-08-10 |
Берінгер Інгельхайм Інтернешнл Гмбх |
Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
|
KR20120061771A
(ko)
*
|
2009-04-30 |
2012-06-13 |
비타이 파마슈티컬즈, 인코포레이티드 |
11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
|
JP5656986B2
(ja)
|
2009-06-11 |
2015-01-21 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
1,3−オキサジナン−2−オン構造に基づく11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
|
US8883778B2
(en)
|
2009-07-01 |
2014-11-11 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
|
CN102753558B
(zh)
*
|
2009-07-31 |
2014-10-15 |
全球结核病药物研发联盟 |
硝基咪唑并噁嗪及其在抗结核治疗中的应用
|
US9198913B2
(en)
|
2009-07-31 |
2015-12-01 |
Global Alliance For Tb Drug Development |
Nitroimidazooxazines and their uses in anti-tubercular therapy
|
CA2769263C
(en)
*
|
2009-07-31 |
2017-03-07 |
Global Alliance For Tb Drug Development |
Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
|
JP5770096B2
(ja)
|
2009-10-26 |
2015-08-26 |
富士フイルムRiファーマ株式会社 |
感染症診断薬
|
TW201200523A
(en)
|
2010-01-29 |
2012-01-01 |
Otsuka Pharma Co Ltd |
Synthetic intermediate of oxazole compound and method for producing the same
|
GB201012209D0
(en)
*
|
2010-05-31 |
2010-09-08 |
Ge Healthcare Ltd |
In vivo imaging agent
|
JP5860042B2
(ja)
|
2010-06-16 |
2016-02-16 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
置換5、6及び7員複素環、そのような化合物を含有する医薬及びそれらの使用
|
WO2011161128A1
(en)
|
2010-06-25 |
2011-12-29 |
Boehringer Ingelheim International Gmbh |
Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
|
EA201300522A1
(ru)
|
2010-11-02 |
2013-11-29 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Фармацевтические комбинации для лечения метаболических нарушений
|
EP2697232B1
(en)
|
2011-04-15 |
2016-05-18 |
Otsuka Pharmaceutical Co., Ltd. |
6,7-dihydroimidazo[2,1-b][1,3]oxazine bactericides
|
JP2015006994A
(ja)
*
|
2011-10-28 |
2015-01-15 |
大正製薬株式会社 |
ジヒドロイミダゾオキサゾール誘導体
|
WO2014014845A1
(en)
|
2012-07-18 |
2014-01-23 |
Vertex Pharmaceuticals Incorporated |
Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases
|
FR3000064A1
(fr)
|
2012-12-21 |
2014-06-27 |
Univ Lille Ii Droit & Sante |
Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes
|
JP6532457B2
(ja)
|
2013-10-04 |
2019-06-19 |
カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ |
6−ニトロ−2,3−ジヒドロイミダゾ[2,1−b]オキサゾール及びこれらの調製方法
|
CN103524492A
(zh)
*
|
2013-10-23 |
2014-01-22 |
中国药科大学 |
侧链含硝基咪唑基团取代的喹诺酮类化合物、其制备及用途
|
TWI687409B
(zh)
|
2014-08-28 |
2020-03-11 |
日商大塚製藥股份有限公司 |
稠合雜環化合物
|
WO2016063298A1
(en)
*
|
2014-10-21 |
2016-04-28 |
Council Of Scientific & Industrial Research |
Substituted 1,2,3-triazol-1-yl-methyl-2,3-dihydro-2-methyl-6-nitroimidazo[2,1-b]oxazoles as anti-mycobacterial agents and a process for the preparation thereof
|
CN105732659B
(zh)
*
|
2014-12-12 |
2019-07-16 |
上海阳帆医药科技有限公司 |
硝基咪唑类化合物及其制备方法和在制药中的用途
|
US10227362B2
(en)
|
2015-01-29 |
2019-03-12 |
Medshine Discovery Inc. |
Anti-pulmonary tuberculosis nitroimidazole derivative
|
LT3275862T
(lt)
|
2015-03-27 |
2020-09-25 |
Otsuka Pharmaceutical Co., Ltd. |
1-(4-hidroksifenil)-4-(4-trifluormetoksifenoksi)piperidino arba jo druskos gamybos būdas
|
CN106317072B
(zh)
*
|
2015-06-17 |
2020-03-17 |
盟科医药技术(上海)有限公司 |
用于分枝杆菌感染治疗的杂环化合物及其应用
|
WO2017146246A1
(ja)
|
2016-02-26 |
2017-08-31 |
大塚製薬株式会社 |
ピペリジン誘導体
|
CN105859628B
(zh)
*
|
2016-04-19 |
2018-08-07 |
清远职业技术学院 |
一种抗菌化合物对n咪唑苯甲醛缩邻甲苯胺希夫碱及其制备方法和应用
|
WO2018014863A1
(zh)
*
|
2016-07-22 |
2018-01-25 |
南京明德新药研发股份有限公司 |
一种硝基咪唑类化合物的晶型、盐型及其制备方法
|
SI3668879T1
(sl)
*
|
2017-08-16 |
2022-04-29 |
Glaxosmithkline Intellectual Property Development Limited |
Nove spojine
|
CN112236141A
(zh)
|
2018-06-11 |
2021-01-15 |
大塚制药株式会社 |
包含德拉马尼的组合物
|
CN109705022A
(zh)
*
|
2018-12-28 |
2019-05-03 |
上海彩迩文生化科技有限公司 |
一种芳香胺中间体的制备方法
|
CN112300192B
(zh)
*
|
2019-08-02 |
2023-08-11 |
南京长澳医药科技有限公司 |
硝基咪唑类化合物及其制备方法和用途
|
CN110483549B
(zh)
*
|
2019-08-30 |
2021-03-05 |
沈阳药科大学 |
一种硝基咪唑吡喃类抗结核药物的制备方法
|
CN110615800A
(zh)
*
|
2019-10-16 |
2019-12-27 |
李丽丽 |
硝基咪唑类化合物及其制备方法和用途
|
CN112156088B
(zh)
*
|
2020-10-30 |
2021-08-31 |
健民药业集团股份有限公司 |
一种化合物在制备结核分枝杆菌抑制剂中的用途
|
CN113603706A
(zh)
*
|
2021-08-04 |
2021-11-05 |
深圳市泰力生物医药有限公司 |
德拉马尼的晶型、含有该晶型的活性药物和药物组合物
|
CN115368252B
(zh)
*
|
2022-09-19 |
2024-01-12 |
西北农林科技大学 |
一种4-胺基酚类衍生物及应用
|
CN116640106B
(zh)
*
|
2023-05-11 |
2024-03-08 |
郑州大学 |
一种苯基哌嗪类化合物及其制备方法、应用
|